Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03423303 | A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)(ProScreen) | enrolling by invitation | N/A | 17,400 | Tampere UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931496 | Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy(PROSTIA- BP) | not yet recruiting | N/A | 150 | Central Hospital, Nancy, FranceOTHER | 1 | Apr 17, 2025 |
| clinicaltrials |
| NCT06926374 | Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery | recruiting | N/A | 90 | Chinese University of Hong KongOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06929884 | Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study | active not recruiting | — | 400 | Qianfoshan HospitalOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT04706962 | TH1902 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 70 | TheratechnologiesINDUSTRY | 2 | Apr 15, 2025 | clinicaltrials |
| NCT06480110 | Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer | recruiting | Phase 1 / Phase 2 | 30 | Rigshospitalet, DenmarkOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06922903 | Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. | not yet recruiting | Phase 3 | 240 | Yunhe Pharmaceutical (Tianjin) Co., LtdOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT01653093 | 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer | active not recruiting | N/A | 280 | University of CincinnatiOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03903835 | ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer(ProBio) | recruiting | Phase 3 | 750 | Karolinska InstitutetOTHER | 4 | Apr 9, 2025 | clinicaltrials |
| NCT06916013 | Focal Laser Ablation in Prostate Cancer | not yet recruiting | — | 30 | Ain Shams UniversityOTHER | 0 | Apr 8, 2025 | clinicaltrials |
| NCT05340374 | Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer(LuCAB) | active not recruiting | Phase 1 / Phase 2 | 35 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05608746 | Prehabilitation in Prostate Cancer Patients, TelePrehabTrial | active not recruiting | N/A | 40 | University of AarhusOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04302454 | Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy(ADOPT) | active not recruiting | Phase 3 | 280 | University Medical Center GroningenOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06740071 | The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy | recruiting | N/A | 100 | The University of Hong KongOTHER | 2 | Apr 4, 2025 | clinicaltrials |
| NCT06850116 | Analysis of Immediate Urinary Continence Predictors After RS-RARP | active not recruiting | — | 400 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06482489 | Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)(Low-PRISM) | recruiting | — | 74 | University of Lausanne HospitalsOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06223022 | Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment | enrolling by invitation | N/A | 512 | Umeå UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT05344235 | Observational Study on Extreme Hypofractionation for Localized Prostate Cancer(OBELIX PCa) | recruiting | — | 246 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05896371 | A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy(PRODIGY-1) | not yet recruiting | Phase 1 / Phase 2 | 500 | CHU de Quebec-Universite LavalOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06895291 | Whole Body MRI in Oncology(ONCO-MRI) | recruiting | — | 1,000 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06900348 | Prostate Specific Antigen Levels of Individuals Living in Rural Areas | not yet recruiting | — | 308 | Suleyman Demirel UniversityOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06901492 | The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture | not yet recruiting | N/A | 120 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT03861507 | Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound | recruiting | N/A | 20 | Western University, CanadaOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC)(PPPC) | enrolling by invitation | — | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06890832 | A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer | not yet recruiting | Phase 2 | 75 | Jina Pharmaceuticals Inc.INDUSTRY | 0 | Mar 24, 2025 | clinicaltrials |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors(ACROPOLI) | active not recruiting | Phase 2 | 184 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06875297 | A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients | not yet recruiting | N/A | 184 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04794777 | Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer | recruiting | Phase 3 | 450 | Stefan CarlssonOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05169112 | Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy | recruiting | Phase 3 | 72 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT03525288 | PSMA-PET Guided Radiotherapy(PSMA-PETgRT) | active not recruiting | Phase 2 / Phase 3 | 130 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04100174 | Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy(fBTsRT) | recruiting | Phase 2 | 150 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04557501 | PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer(PATRON) | active not recruiting | Phase 3 | 800 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06505356 | Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage | enrolling by invitation | N/A | 400 | Edgaras BurzinskisOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT05523856 | New Treatment Modalities for Localized Prostate Cancer(TTOPROST/OBS) | active not recruiting | — | 480 | Fundacion IMIMOTHER | 0 | Mar 12, 2025 | clinicaltrials |
| NCT06652607 | PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer(PSA-DEEP02) | recruiting | — | 152 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06863090 | In Vivo Dosimetry for Brachytherapy Study | recruiting | — | 20 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06866782 | European Registry of Next Generation Imaging in Advanced Prostate Cancer(RING) | recruiting | — | 600 | Fundacio PuigvertOTHER | 8 | Mar 11, 2025 | clinicaltrials |
| NCT03987633 | EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality(EMPOWER) | recruiting | — | 200,000 | Future Genetics LimitedOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06866795 | Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC) | not yet recruiting | Phase 1 | 42 | Geode Therapeutics Inc.INDUSTRY | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06864572 | [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06446401 | The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer(Lead4Care) | recruiting | — | 1,400 | Uppsala UniversityOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06565247 | Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation | recruiting | Phase 3 | 60 | Region VästerbottenOTHER_GOV | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06855589 | Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.(PCS-XII) | not yet recruiting | Phase 3 | 400 | Charles LeMoyne HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT01492751 | Effectiveness of Localized Prostate Cancer Treatments(E-PROSTCaT) | active not recruiting | — | 500 | Fundacion IMIMOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06783829 | A Study of SHR-4394 Injection in Subjects With Prostate Cancer | recruiting | Phase 1 | 240 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06850545 | Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer(KuPSMALu) | recruiting | — | 150 | Kuopio University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06844513 | Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform(URO-ROBOT-2023) | not yet recruiting | N/A | 800 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06766526 | Internet-based Support for Adjustment to Prostate Cancer(ISAC) | recruiting | N/A | 180 | Linkoeping UniversityOTHER_GOV | 1 | Feb 24, 2025 | clinicaltrials |
| NCT03822494 | CyberKnife Dose Escalation Prostate Cancer Trial(CK-DESPOT) | active not recruiting | N/A | 100 | Crozer-Keystone Health SystemOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05000827 | Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients(PSMA-SELECT) | recruiting | N/A | 706 | Canisius-Wilhelmina HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Apr 17, 2025source: clinicaltrials